Group managing director, Leonard Ariff Abdul Shatar, attributed the group’s strong performance to higher demand for the group’s pharmaceutical products from both the private and public health sectors.
KUALA LUMPUR: Duopharma Biotech Bhd
(formerly CCM Duopharma Biotech Bhd) posted net profit of RM55.27mil in the financial year ended Dec 31,2019 and was upbeat on its outlook for its pharmaceutical products due to the extension of contract periods by the government.
It announced on Thursday its net profit had increased by 16% from RM47.64mil in FY18. Its revenue rose by 15.6% to RM576.46mil from RM498.72mil.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
